No Data
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
ACELYRIN Shares Are Trading Higher After Wells Fargo Upgraded the Stock From Equal-Weight to Overweight and Maintained Its $13 Price Target.
ACELYRIN Price Target Maintained With a $13.00/Share by Wells Fargo
Wells Fargo Upgrades ACELYRIN to Overweight From Equalweight, Price Target at $13
Wells Fargo Upgrades Acelyrin(SLRN.US) to Buy Rating, Maintains Target Price $13
Wells Fargo analyst Derek Archila upgrades $Acelyrin(SLRN.US)$ to a buy rating, and maintains the target price at $13.According to TipRanks data, the analyst has a success rate of 42.3% and a total av
Express News | ACELYRIN Inc : Wells Fargo Raises to Overweight From Equal-Weight
No Data